Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (151-160 of 429) with videos related to

Pageof 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancersKenneth Offit, Shlomit Gilad, Shoshana Paglin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cellsStephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
American Journal of Medical Genetics. Part A|December 22, 2025
Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the RTEL1 R1264H Founder VariantLauren G Banaszak, Elise Fiala, Ozge Ceyhan-Birsoy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity FrameworkBryce A Seifert, Jennifer L McGlaughon, Sarah A Jackson, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Human Mutation|October 13, 2018
Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genesMichael F Walsh, Deborah I Ritter, Chimene Kesserwan, et al.
Gynecologic Oncology|May 23, 2021
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysisJenny Lin, Ravi N Sharaf, Rachel Saganty, et al.
BMC Medical Research Methodology|August 19, 2020
Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trialLydia E Pace, Yeonsoo S Lee, Nadine Tung, et al.
European Journal of Human Genetics : EJHG|February 6, 2019
Case-control analysis identifies shared properties of rare germline variation in cancer predisposing genesMykyta Artomov, Vijai Joseph, Grace Tiao, et al.
Nature Communications|November 23, 2022
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologiesYonina R Murciano-Goroff, Alison M Schram, Ezra Y Rosen, et al.
Pageof 43

Showing results (151-160 of 429) with videos related to

Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancersKenneth Offit, Shlomit Gilad, Shoshana Paglin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cellsStephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
American Journal of Medical Genetics. Part A|December 22, 2025
Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the RTEL1 R1264H Founder VariantLauren G Banaszak, Elise Fiala, Ozge Ceyhan-Birsoy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity FrameworkBryce A Seifert, Jennifer L McGlaughon, Sarah A Jackson, et al.
International Journal of Cancer|December 7, 2005
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an updateJacek Gronwald, Nadine Tung, William D Foulkes, et al.
Human Mutation|October 13, 2018
Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genesMichael F Walsh, Deborah I Ritter, Chimene Kesserwan, et al.
Gynecologic Oncology|May 23, 2021
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysisJenny Lin, Ravi N Sharaf, Rachel Saganty, et al.
BMC Medical Research Methodology|August 19, 2020
Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trialLydia E Pace, Yeonsoo S Lee, Nadine Tung, et al.
European Journal of Human Genetics : EJHG|February 6, 2019
Case-control analysis identifies shared properties of rare germline variation in cancer predisposing genesMykyta Artomov, Vijai Joseph, Grace Tiao, et al.
Nature Communications|November 23, 2022
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologiesYonina R Murciano-Goroff, Alison M Schram, Ezra Y Rosen, et al.
Pageof 43